Protagonist Therapeutics, Inc

Ownership Transactions Reported by 13 Insiders

Symbol
PTGX on Nasdaq
Location
7707 Gateway Blvd., Suite 140, Newark, CA

Insiders trading volume in the past year

Protagonist Therapeutics, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dinesh V. Patel President and CEO, Director $28.6M -$8.34M -22.6% Sep 16, 2025
Arturo Molina Chief Medical Officer $6.88M -$4.47M -39.4% Nov 17, 2025
David Y. Liu Chief R&D Strategy Officer $4.13M Nov 16, 2022
Suneel Gupta Chief Development Officer $3.25M -$5.64M -63.4% Nov 25, 2024
Asif Ali Chief Financial Officer $2.81M -$1.54M -35.5% Apr 22, 2025
Bryan Giraudo Director $1.04M Jan 2, 2025
Donald A. Kalkofen Chief Financial Officer $456K Feb 15, 2022
William D. Waddill Director $450K -$1.69M -79% Oct 10, 2025
Lewis T. Williams Director $230K Jan 2, 2025
Sarah A. O'Dowd Director $230K Jan 2, 2025
Harold E. Selick Director $50.9K Apr 28, 2025
Daniel N. Swisher JR Director Oct 26, 2023
Sarah B. Noonberg Director Jan 16, 2023

Recent Insider Transactions by Companies or Individuals for Protagonist Therapeutics, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.